FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20319711000001102: Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68434601000001119 Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68434701000001112 Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Is a Pioglitazone 15mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has AMP Pioglitazone 15mg tablets (Sandoz Ltd) true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has specific active ingredient Pioglitazone hydrochloride true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pioglitazone true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Has basis of strength substance Pioglitazone true Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Sandoz Ltd) 28 tablet Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start